Loading…
Cardiol Therapeutics Inc. is projected to rise to $1.16 by 2027, a +14% move from its current price of $1.01. CRDL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.9899 | $1.01 | $1.03 | +0.01% |
| Jul 15 | $0.9817 | $1.01 | $1.04 | +0.03% |
| Jul 16 | $0.9756 | $1.01 | $1.05 | +0.04% |
| Jul 17 | $0.9704 | $1.01 | $1.05 | +0.06% |
| Jul 18 | $0.9659 | $1.01 | $1.06 | +0.07% |
| Jul 19 | $0.9619 | $1.01 | $1.06 | +0.09% |
| Jul 20 | $0.9582 | $1.01 | $1.07 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9582 | $1.01 | $1.07 | +0.10% |
| Week 2 | $0.9381 | $1.01 | $1.09 | +0.20% |
| Week 3 | $0.9232 | $1.01 | $1.11 | +0.30% |
| Week 4 | $0.911 | $1.01 | $1.13 | +0.40% |
| Week 5 | $0.9004 | $1.02 | $1.14 | +0.50% |
| Week 6 | $0.8911 | $1.02 | $1.16 | +0.60% |
| Week 7 | $0.8826 | $1.02 | $1.17 | +0.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardiol Therapeutics Inc. is a clinical-stage life sciences company that focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate CardiolRx is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Cardiol Therapeutics Inc. trades under the symbol CRDL and is categorized in Healthcare. The current price is $1.03 and the market cap is $118.73M, with a rank of 4071.
The technical picture shows a NEUTRAL sentiment with RSI14 at 30, SMA50 at $1.31, and SMA200 at $1.11. The stock’s 30-day range spans from $0.8687 to $1.22, with near-term support at $1.03 and resistance at $1.37.
The multi-year forecast indicates a bullish long-term path, with the average price rising from $1.03 in 2026 to $1.29 by 2030 and continuing higher to $3.12 by 2040 and $4.91 by 2050. Corresponding ROIs rise to 24.8% by 2030, 203.2% by 2040, and 377.2% by 2050, underscoring a strong long-range appreciation potential.
A major floor 20.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 26.7% above — a clean break opens room to run.
A major ceiling 61.4% above — clearing it would confirm fresh momentum.
Key CRDL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRDL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.02 | Sell | $1.01 | Sell |
| MA 10 | $1.03 | Sell | $1.03 | Sell |
| MA 20 | $1.04 | Sell | $1.05 | Sell |
| MA 50 | $1.17 | Sell | $1.13 | Sell |
| MA 100 | $1.18 | Sell | $1.15 | Sell |
| MA 200 | $1.11 | Sell | $1.16 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.15 | Neutral |
| Stoch RSI (14) | 48.47 | Neutral |
| CCI (20) | -110.34 | Sell |
| Williams %R (14) | -76.92 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -3.81 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 23.08 | Neutral |
| TRIX (15) | -0.63 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 32.34 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.99 | Buy |
| ADX (14) | 29.53 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30 and moving averages showing a near-term crossover context: SMA50 at $1.31 and SMA200 at $1.11.
Price action is trading around support at $1.03 with resistance at $1.37, while the 30-day range runs from $0.8687 to $1.22. This setup suggests a balance between downside risk and upside potential over the near term.
Annualized volatility is 50%, indicating a relatively high level of price swings relative to the price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.926 | $1.01 | $1.25 | 0% | Neutral | |
| $0.9423 | $1.16 | $1.49 | +14% | Neutral | |
| $0.938 | $1.17 | $1.55 | +16% | Neutral | |
| $0.9713 | $1.24 | $1.67 | +22% | Bullish | |
| $1.04 | $1.34 | $1.85 | +33% | Bullish | |
| $1.11 | $1.45 | $2.03 | +44% | Bullish | |
| $1.36 | $1.81 | $2.57 | +79% | Bullish | |
| $1.46 | $1.96 | $2.83 | +94% | Bullish | |
| $1.43 | $1.94 | $2.84 | +92% | Bullish | |
| $1.59 | $2.17 | $3.20 | +115% | Bullish | |
| $2.25 | $3.23 | $5.01 | +219% | Bullish | |
| $3.41 | $5.27 | $8.81 | +422% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.926 | $1.01 | $1.18 | +0.00% |
| August 2026 | $0.8608 | $1.01 | $1.21 | -0.10% |
| September 2026 | $0.8685 | $1.02 | $1.24 | +1.42% |
| October 2026 | $0.8484 | $1.00 | $1.22 | -1.89% |
| November 2026 | $0.833 | $0.9895 | $1.21 | -1.44% |
| December 2026 | $0.8512 | $1.01 | $1.25 | +2.55% |
Click any year to see its month-by-month CRDL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CRDL to range from $0.926 to $1.25 through 2026. The $1.01 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CRDL price prediction for 2027 points to an average of $1.16 (low $0.9423, high $1.49) — a potential gain of +14% on today's $1.01. A consolidation phase looks the most probable path here.
In 2028, CRDL is projected to trade between $0.938 and $1.55, averaging $1.17 — a potential gain of +16% from today's $1.01. That is up +2% on the projected 2027 average. Price action looks broadly range-bound.
Cardiol Therapeutics Inc.'s 2029 outlook centres on $1.24, within a $0.9713 to $1.67 range. That is up +5% on the projected 2028 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CRDL could reach as high as $1.85, with a base case around $1.34 and support toward $1.04 — roughly +33% from $1.01. Momentum favours further upside here.
Expect CRDL to range from $1.11 to $2.03 through 2031. The $1.45 average target implies a +44% move from current prices. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CRDL price prediction for 2032 points to an average of $1.81 (low $1.36, high $2.57) — a potential gain of +79% on today's $1.01. Momentum favours further upside here.
In 2033, CRDL is projected to trade between $1.46 and $2.83, averaging $1.96 — a potential gain of +94% from today's $1.01. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Cardiol Therapeutics Inc.'s 2034 outlook centres on $1.94, within a $1.43 to $2.84 range. That is -1% versus the projected 2033 average. That marks a +92% change versus current levels. Momentum favours further upside here.
By 2035, CRDL could reach as high as $3.20, with a base case around $2.17 and support toward $1.59 — roughly +115% from $1.01. Buyers look set to stay in control over this stretch.
Expect CRDL to range from $2.25 to $5.01 through 2040. The $3.23 average target implies a +219% move from current prices. That is up +49% on the projected 2035 average. Momentum favours further upside here.
The CRDL price prediction for 2050 points to an average of $5.27 (low $3.41, high $8.81) — a potential gain of +422% on today's $1.01. Buyers look set to stay in control over this stretch.
Investing $1,000 in CRDL today (≈ 990.09901 CRDL) could be worth
$5,221.73
+$4,221.73 (+422%) by 2050 · US Dollar
Based on the average projected CRDL price of $5.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRDLwould be worth at today's price.
$1,000 invested in CRDL on Jul 10, 2025 (≈ 729.927005 CRDL) would be worth
$737.23
-$262.77 (-26.3%) today · 0.74× · US Dollar
Based on a CRDL entry price of $1.37 vs. today's $1.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.05 | $961.9 | -3.8% |
| 1 month ago | $1.05 | $961.9 | -3.8% |
| 3 months ago | $1.38 | $731.88 | -26.8% |
| 6 months ago | $0.96 | $1,052.08 | +5.2% |
| 1 year ago | $1.37 | $737.23 | -26.3% |
| All time (5.0y) ago | $2.36 | $427.97 | -57.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRDL forecast.
Our base-case forecast reaches $2.00 around 2035.
Implied market cap at $2.00: $230.54M
The multi-year forecast turns bullish from 2030 onward, with meaningful upside implied in the Avg price and ROI numbers.
2030 shows an avg of $1.29 with a ROI of 24.8% and a bullish sentiment, marking a shift from earlier neutral readings to stronger upside potential.
2040 strengthens the outlook, with an avg of $3.12 and a ROI of 203.2%, maintaining a bullish stance and signaling substantial appreciation potential relative to earlier years.
2050 extends the bullish trajectory to an avg of $4.91 and a ROI of 377.2%, with a max forecast approaching $8.91 and a near-term path that remains elevated compared with today. While these figures illustrate potential, they are not guarantees and carry inherent investment risk.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $1.29, with a min of $0.9605 and a max of $1.85, and a ROI of 24.8%; sentiment is BULLISH.
Forecasts indicate NEUTRAL sentiment in 2026–2029, turning BULLISH from 2030 onward. The ROI progresses to 24.8% by 2030 and 377.2% by 2050, with a max price forecast of $8.91 by 2050.
Yes. The 2040 max is $5.19, and the 2050 max is $8.91, with an average by 2050 of $4.91, indicating a path that could surpass $5 by 2040.
Current price is $1.03 and market cap is $118.73M; the asset ranks 4071.
RSI14 is 30; SMA50 is $1.31; SMA200 is $1.11. The 30-day range is $0.8687 to $1.22, with support at $1.03 and resistance at $1.37; annualized volatility is 50%.
Cardiol Therapeutics Inc. Community Discussion
0Share your Cardiol Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.